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Summary In a population-based case-control study in the Uppsala-Orebro Health Care Region of Sweden, the histories of cancer among
parents of 517 histologically confirmed cases of papillary and follicular carcinoma and of a similar number of sex- and age-matched controls
were compared. The parental history of cancer was compiled through information from death certificates and from the nationwide Cancer
Register. The incidence of malignancies in a cohort of parents of cases of thyroid cancer was also compared with the incidence in the whole
Swedish population. A maternal history of cancer was more common among women with follicular carcinoma than among their controls (OR
2.11, 95% Cl 0.96-4.67). Parents of probands with papillary carcinoma had an increased risk of thyroid cancer (OR 4.25, 95% Cl
1.16-10.89), and mothers of probands with follicular carcinoma had an increased risk of stomach cancer (OR 3.65, 95% Cl 0.99-9.35)
compared with the general population. Cancer of the lung, breast, and pancreas were less common than in the general population. Familial
cases ofthyroid cancer were not limited to the papillary type. An inheritable pattern ofcarcinogenesis is possible forcertain differentiated non-
medullary thyroid cancers, but shared environmental exposures may also explain the parent-child associations of cancer in this study.
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A genetic inheritable component has not been established for
differentiated thyroid carcinomas arising from the follicular epithe-
lium, although family clusters have been repeatedly documented
(Ozaki et al, 1988; Fischer et al, 1989; Ron et al, 1991; Gorson et
al, 1992; Kobahashi et al, 1995), particularly forthe papillary type.
However, most of these reports were based on small case series
from hospitals. A general susceptibility to cancer in families of
patients of non-medullary thyroid carcinoma has not been studied
extensively. One reason is the relative rarity of this cancer form,
which makes it difficult to put together large case series. Another
reason is the difficulty to obtain a reliable medical history
concerning family members. Although death as the result ofcancer
as such seems to be accurately recalled by close relatives (Tepperet
al, 1993), the tumour site may be misclassified (Love et al, 1985),
and accuracy of the reported diagnoses may differ between rela-
tives who have themselves a similar disease and those who do not.
The aim of this study was to assess the cancer occurrence in
families ofpatients with non-medullary carcinoma of the thyroid,
focusing on the association with parental cancer. We conducted a
population-based case-control study, using the unique setting in
Sweden that enables a uniform follow-up of persons with respect
to cancer occurrence.
MATERIALS AND METHODS
Cases and controls
The study was approved by the Ethics Advisory Board at the
University Hospital in Uppsala. The process of selection of cases
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and controls has been described elsewhere (Galanti et al, 1995)
and will, therefore, only be summarized here.
We initially identified 632 patients with a diagnosis ofpapillary
or follicular thyroid cancer reported to the Swedish Cancer
Registry or to the Regional CancerRegistry in the Uppsala-Orebro
Health Care Region between 1 January 1980 and 30 September
1993. We performed a thorough review of the histological speci-
mens of the potentially eligible cases, and 541 cases (85.6%)
whose diagnoses were confirmed were classified according to the
revised WHO classification system for thyroid tumours (Hedinger
et al, 1988). The review was carried out to both avoid misclassifi-
cation, which is rather common for the follicular form (Li Volsi
and Asa, 1994), and to have a uniform and updated classification.
All cases had to have been born and permanently resident in
Sweden. One control person for each case, with the same charac-
teristics as to birthplace and residence, was selected from the
Register of the Total Population and individually matched by sex,
birth-year and county of residence at the date of diagnosis of the
corresponding case.
Parents identification
The basis for the identification of parents was provided by the
probands' (cases and controls) national registration number
(NRN), assigned in 1947 and thereafter at birth to every Swedish
resident. In Sweden, parish administrative offices were respon-
sible for the registration of all vital events up to June 1991. We
used the NRN to contact the parish authorities at the subjects'
birthplace and at each place ofresidence oftheirparents thereafter.
The information collected about parents from the parish offices
included birthdate, national identification number, if they were
alive in 1947, living status on 1 January 1958 (when the Swedish
Cancer Register was implemented) and date and cause of death if
they had died before that date.
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Table 1 Cases of thyroid cancer by sex, age and histopathological type (matched case-control design) in Uppsala, Sweden, 1980-93
Men Women All cases
Age (years) Papillary type Follicular type All men Papillary type Follicular type All women Papillary type Follicular type
0-19 1 - 1 14 - 14 15 -
20-29 3 - 3 32 5 37 35 5
30-39 11 1 12 56 9 65 67 10
40-49 23 5 28 53 14 67 76 19
50-59 16 5 21 49 10 59 65 15
60-69 12 10 22 38 23 61 50 33
>70 26 12 38 53 36 89 79 48
All cases 92 33 125 295 97 392 387 130
(%) (73.6) (26.4) (100.0) (72.3) (24.7) (100.0) (74.9) (25.1)
For 15 cases and ten controls, it was not possible to identify or
follow up any of the biological parents; for 21 cases and 20
controls, only one biological parent could be traced; and anomalies
in the ascertainment ofthe NRN were detected for 12 parents (six
cases, six controls). A total of 2033 parents were thus identified,
corresponding to 526 cases (97.2%) and 531 controls (98.2%) with
at least one parent traced. Identification of both parents was
possible for 499 cases (92.2%) and 492 controls (93.2%).
Cancer diagnosis among the parents
To determine the occurrence of cancer in the parents, we used two
different sources of information. For persons who died before the
introduction of the Swedish Cancer Registry, we used the death
certificateprovidedby theparish authorities andassumed adiagnosis
of malignancy if this was included among death causes. The three-
digit code ofthe Seventh International Classification ofDiseases and
Causes of Death for tumours (ICD7, codes 140-239) was used to
describe the cancer site. Only the first cancer site was recorded and
assumed to be the primary site in case ofmetastatic tumours.
For persons still alive on 1 January 1958, we ascertained the
cancer diagnosis by matching their NRN with the Swedish Cancer
Register. The Cancer Register receives compulsory notification of
all instances of primary malignancies, of some precancerous
lesions and some non-malignant neoplasms (central nervous
system and meninges, endocrine glands excluding thyroid, papil-
lomas of the urinary tract). Cases of tumours are reported sepa-
rately by physicians and by pathologists or cytologists. The
completeness ofthe register is estimated to be close to 100%. For
the purpose ofthis study, the linkage was updated to the year 1992.
All diagnoses of primary malignancies were considered, irrespec-
tive of their modality of ascertainment (including, therefore,
tumours diagnosed at autopsy).
Through the National Register ofthe Causes ofDeath, started in
1952, we ascertained the living status and the cause of death also
for parents who were alive in 1958. In order to extend the sensi-
tivity of the registration to prevalent cancers not captured by the
recording of incidence, a cancer diagnosis was also set if cancer
was listed as underlying cause of death, irrespective of its
recording in the National Cancer Register (18 parents ofcases, 15
parents ofcontrols).
Statistical analysis
Case-control study
We used amatched case-control designtoanalyse the odds ratio (OR)
ofhaving ahistory ofcancer among parents, categorized as follows:
(a) any cancer diagnosis for the mother (irrespective ofthe
father's status);
(b) any cancer diagnosis for the father (irrespective ofthe
mother's status);
(c) any cancer diagnosis for either one ofthe parents;
(d)diagnosis ofany cancer in both parents;
(e) multiple diagnosis ofcancer (highest number ofdiagnoses=2)
in at least one ofthe parents (only among subjects with at least
one parent alive on 1 January 1958).
Variables used for adjustment in the multivariate models
included: numberofascertained parents, living status ofeach parent
in 1958 and age of each parent at the proband's birth. This latter
variable was analysed in both continuous and categorized form, age
categories corresponding toquartiles ofdistribution among controls.
Separate analysis was done according to sex, age at diagnosis and
histopathological type of the probands. Logistic regression models
were fitted using conditional maximum likelihood equations for
matched case-control studies (Breslow and Day, 1980).
Cancerincidence in a cohortofparents
The incidence of cancer at specific sites (ICD7 140-207) was
studied in the cohort of778 parents ofthyroid cancerpatients alive
at the date when the cancer registration started in Sweden on 1
January 1958. Follow-up began on this date or the index child's
date of birth, if born after this date. For each cancer site, the
subjects in the cohort accrued person-years at risk until the date of
diagnosis, if any, or until the date of death or until 31 December
1992, whichever occurred first. Seven parents whose dates of
death were discordant in different sources, or who would other-
wise be more than 100 years old at the end of follow-up, were
contributing person-years up to the midpoint of the follow-up
period. As a measure ofassociation, we used the standardized inci-
dence ratios (SIRs) and their exact 95% confidence interval (CI),
assuming the observed number of events to follow a Poisson
distribution (Breslow and Day, 1987). To calculate the expected
cancer in the cohort, we used the national population age- and sex-
specific incidence rates by quinquennia of age (0-4, 5-9 years
etc.) and calendar period (1958-62, 1963-67, etc.). The rates in
the period 1988-91 were also applied to the year 1992. For all
cases ofparathyroid tumours (n=4), the original notification to the
Cancer Register was examined. In all instances, a diagnosis of
adenoma was clearly stated. However, these cases are included in
the calculation of the SIR for all cancers, because they contribute
to the national incidence rates and, therefore, to the expected
number ofcancers as well.
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Table 2 Relative risk (OR) of thyroid cancer by parental history of any cancer
in a matched case-control study, Uppsala, Sweden, 1980-93
History of cancer (yes vs no) Cases (n) Controls (n) OR Clb
Any of the parents 192 174 1.11 0.85-1.46
Mother 103 84 1.27 0.91-1.78
Father 109 105 1.05 0.77-1.43
Both parentsa 20 15 1.39 0.69-2.79
aNo = no cancer in any of the parents. bCl 95% confidence interval.
RESULTS
Case-control study
The study encompassed 517 age- and gender-matched case-control
sets. Table 1 gives information on the patients' age, gender and
histological type ofthyroid cancer.
Relative risk ofparental cancer
No association was found between a parental diagnosis of cancer
and risk of thyroid cancer (Table 2). Having a mother or both
parents with a cancer seemed to convey a slightly increased risk,
but could be owing to chance. There was an equal number ofcases
and controls (n=8) with a parent with a second diagnosis of
primary cancer, after exclusion of diagnoses of parathyroid
adenoma and ofsites not specified as primary.
When the probands were analysed separately by sex and
histopathological form, a positive association of borderline statis-
tical significance was apparent between maternal cancer and
thyroid cancer among women (OR 1.43, 95% CI 0.97-2.10),
particularly those women with a diagnosis offollicular carcinoma
(OR 2.11,95% CI 0.96-4.67). This latter association was strength-
ened when the number of ascertained parents and the living status
ofthe mother were included in the multivariate analysis (OR 2.35,
95% CI 1.03-5.37).
In the multivariate analysis, all the associations with parental
history ofcancer were not substantially altered after adjustment for
parent's age at the proband's birth.
Age ofparents at the proband's birth
Both parents of controls were, on average, older than parents of
cases when their index child was born. When analysed in regres-
sion models, this difference resulted in a decreased risk with
increasing quartiles of paternal and maternal age at the proband's
birth, although the estimates attained a borderline statistical signif-
icance only for paternal age (Table 3). Paternal and maternal age,
however, were strongly positively correlated (Pearson r=0.74). In
a separate analysis using sex of the probands as a variable (not
shown), these results held true and were even strengthened among
women, but not among men. When parental age was analysed in
the continuous form, women had a 3% significant reduction in risk
for each year of increasing paternal age and maternal age (OR
0.97, 95% CI 0.95-0.99) at the time of their birth. The same
tendency was seen in the subset of papillary carcinoma, while the
analysis of follicular carcinoma was hampered by the paucity of
the observations.
The results did not change after mutual adjustment by history of
cancer in either parent or both.
Table 3 Relative risk of thyroid cancer by parental age at the proband's birth
in a matched case-control study, Uppsala, Sweden, 1980-93
Cases (n) Controls(n) OR CIa
Father's age (years)
< 27 171 134 1 Reference
28-32 137 138 0.74 0.54-1.03
33-37 99 112 0.72 0.50-1.04
38+ 91 114 0.60 0.41-0.88
X,2 trend=6.87 (P=0.009)
Per year of increasing age 0.98 0.96-1.00
Mother's age (years)
< 23 142 136 1 Reference
24-28 165 141 1.11 0.80-1.52
29-33 113 128 0.81 0.58-1.15
34+ 89 108 0.78 0.53-1.14
X,2 trend=2.94 (P=0.087)
Per year of increasing age 0.98 0.96-1.00
aCl, 95% confidence interval.
SIR of cancer among parents
There were 147 cases of cancer in the cohort of 778 parents of
cases ofthyroid cancer (SIR 1.05,95% CI 0.88-1.23), contributing
slightly more than 18 000 person-years at risk during the follow-
up period.
Table 4 reports the relative risk ofspecific cancer sites (ICD7 3-
digit classification) by sex of the parents. Increased risk, although
not statistically significant, was found for malignant neoplasms of
the thyroid gland, especially among women (SIR 3.54, 95% CI
0.73-10.36) who also had increased risk of stomach cancer (SIR
2.27,95% CI 1.04-4.31) and ofparathyroid adenomas.
There was also an excess risk for cancer of the nasopharynx
among women and of the pharynx among men, the latter being
statistically significant (SIR 69.36, 95% CI 1.76-386.47) but
based on only one case in each instance. A significant excess of
malignancies of nose and sinuses was also observed among males,
with two observed cases vs 0.2 expected (Sir 9.78, 95% CI
1.18-35.32).
In this cohort the SIR was lower than expected for cancer of
several sites. The most striking deficits occurred in lung cancer
among men, with only one case observed vs 7.49 expected (SIR
0.13, 95% CI 0.00-0.74), in breast cancer among women (SIR
0.57, 95% CI 0.27-1.05) and in tumours of the pancreas in both
sexes (SIR 0.18, 95% CI 0.00-1.03). Other deficits (although
based on very few observed and/or expected cases) included:
anorectal and ovary cancer among women and, in both sexes,
malignant melanoma, non-Hodgkin lymphoma and plasmocy-
toma. These deficits were apparently not as the result of elevated
early mortality for these malignancies, the proportions such deaths
being practically identical between those parents ofthyroid cancer
cases and those parents ofcontrols who died before 1958. A slight
excess, yet largely compatible with chance, was found only for
breast cancer among mothers of cases.
A separate analysis of incidence among parents of female
probands (607 subjects) did not reveal any further difference, and
likewise when the analysis was restricted to the 619 parents whose
children were diagnosed with papillary carcinoma. However, in
this latter group, the SIR for thyroid neoplasms was significantly
higher than in the whole cohort (SIR 4.25, 95% CI 1.16-10.89).
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Table 4 Standardized incidence ratio (SIR) of cancer at different sites in a cohort of parents of patients with papillary and follicular carcinoma of the thyroid,
Uppsala, Sweden, 1958-92
Both sexes Males Females
Site Cases SIR CIa Cases SIR CIa Cases SIR CIa
(Three-digitlCD7) 0 E 0 E 0 E
All sites (140-207)b
Lip (140)
Nasopharynx (146)
Pharynx, unspecified (148)
Oesophagus (150)
Stomach (151)
Colon (153)
Rectum and anus (154)
Biliary passages and liver,
primary (155)
Liver, not specified (156)
Pancreas (157)
Nose and nasal sinuses (160)
Larynx (161)
Trachea, bronchus, lung
and pleura (162)
Lung, not specified as
primary (163)
Breast (170)
Cervix uteri (171)
Corpus uteri (172)
Ovary, tube and broad
ligament (175)
Other female genitals (176)
Prostate (177)
Kidney (180)
Other urinary organs (181)
Malignant melanoma of
the skin (190)
Skin, excluded melanoma (191)
Eye (192)
Nervous system (193)
Thyroid (194)
Other endocrine (195)c
Bone (196)
Connective tissue, muscle (197)
Non-Hodgkin lymphoma (200)
Hodgkin's disease (201)
Plasmacytoma (203)
Lymphatic leukaemia (204)
Myeloid leukaemia (205)
Other/unspecified site (199)
147 140.3
2 0.94
1 0.21
1 0.02
1 1.46
16 10.67
15 12.00
6 6.96
4 4.77
1 0.57
1 5.41
2 0.33
1 0.85
1.05
2.12
4.71
46.61
0.69
1.50
1.25
0.86
0.84
1.75
0.18
6.03
1.17
0.88-1.23
0.26-7.65
0.12-26.22
1.18-259.69
0.02-3.82
0.86-2.43
0.70-2.06
0.32-1.88
0.23-2.15
0.04-9.73
0.00-1.03
0.73-21.78
0.03-6.52
77 70.82
2 0.82
0 0.13
1 0.01
1 1.01
7 6.71
7 5.80
6 3.96
0 2.08
0 0.29
1 2.86
2 0.20
1 0.77
1.09
2.43
0.00
69.36
0.99
1.04
1.24
1.51
0.00
0.00
0.35
9.78
1.30
0.86-1.36
0.29-8.76
0.00-23.07
1.76-386.47
0.03-5.51
0.42-2.15
0.48-2.48
0.56-3.30
0.00-1.44
0.00-10.34
0.01-1.95
1.18-35.32
0.03-7.24
70 69.53
0 0.12
1 0.08
0 0.01
0 0.45
9 3.97
8 6.19
0 3.00
4 2.69
1 0.28
0 2.55
0 0.13
0 0.09
1.01
0.00
12.36
0.00
0.00
2.27
1.29
0.00
1.49
3.58
0.00
0.00
0.00
0.78-1.27
0.00-25.00
0.31-68.84
0.01-300.0
0.00-6.67
1.04-4.31
0.56-2.55
0.00-1.00
0.41-3.81
0.09-19.97
0.00-1.18
0.00-23.08
0.00-33.33
4 9.93 0.40 0.11-1.03 1 7.49 0.13 0.00-0.74 3 2.44 1.23 0.25-3.59
1 0.60
11 17.70
5 5.20
5 6.66
1 2.81
6 5.08
1 0.39
3 4.01
4 1.19
4 1.91
1 0.22
1 0.93
1 3.36
1 0.83
1 2.15
4 2.85
1 0.81
8 4.73
1.68
0.62
0.96
0.75
0.36
1.18
2.57
0.75
3.35
2.09
4.50
1.08
0.30
1.20
0.46
1.40
1.24
1.69
0.04-9.36 0 0.40
0.31-1.11 1 0.13
22 17.52
0.31-2.24 2 3.01
0.24-1.75 5 4.85
0.01-1.99
0.43-2.57
0.06-14.29
0.15-2.19
0.91-8.59
0.57-5.36
0.11-25.07
0.03-6.00
0.01-1.66
0.03-6.70
0.01-2.59
0.38-3.59
0.03-6.90
0.73-3.34
0 1.31
3 3.26
1 0.20
1 1.80
1 0.35
0 0.59
1 0.12
1 0.48
1 1.78
0 0.48
0 1.17
4 1.69
1 0.41
4 2.14
0.00 0.00-7.50 1 0.20
7.67 0.19-42.71 10 17.57
2 2.86
6 4.04
1.26 0.79-1.90
0.66 0.08-2.40
1.03 0.34-2.41
0.00
0.92
4.97
0.56
2.89
0.00
8.54
2.09
0.56
0.00
0.00
2.36
2.42
1.87
0.00-2.29
0.19-2.69
0.13-27.70
0.01-3.09
0.07-16.11
0.00-5.08
0.22-47.59
0.05-11.64
0.01-3.13
0.00-6.25
0.00-2.56
0.64-6.05
0.06-13.49
0.51-4.78
2 4.28
1 0.76
3 2.19
0 1.81
1 1.49
3 1.82
0 0.19
2 2.21
3 0.85
4 1.32
0 0.11
0 0.45
0 1.58
1 0.35
1 0.98
0 1.16
0 0.39
4 2.58
5.07 0.13-28.24
0.57 0.27-1.05
0.70 0.08-2.52
1.49 0.55-3.24
0.47
1.31
1.37
0.00
0.67
1.65
0.00
0.91
3.54
3.03
0.00
0.00
0.00
2.86
1.02
0.00
0.00
1.55
0.06-1.69
0.03-7.32
0.28-4.01
0.00-1 .66
0.02-3.73
0.34-4.81
0.00-15.79
0.11-3.27
0.73-10.36
0.83-7.76
0.00-27.27
0.00-6.67
0.00-1.90
0.07-15.92
0.03-5.66
0.00-2.59
0.00-7.69
0.42-3.97
aCl, exact 95% confidence intervals. bOnly sites with at least one observed or expected case are included in the table. For each specific site, person-time at risk
was contributed also from subjects with other cancer diagnoses. Therefore, the sum of expected cases at specific sites does not equal the number of expected
cancer at all sites. cParathyroid adenomas. 0, observed; E, expected.
Table 5 Standardized incidence ratios (SIRs) of selected parental cancer sites by histopathological type of the probands
Papillary carcinoma Follicular carcinoma
0 E SIR 95%CI 0 E SIR 95%CI
Site/Parents
All sites/All 107 108.4 0.99 0.81-1.19 40 31.93 1.25 0.90-1.71
Corpus uteri/Mothers 3 3.23 0.93 0.19-2.71 3 0.81 3.72 0.77-10.87
Breast/Mothers 7 13.91 0.50 0.20-1.04 3 3.66 0.82 0.17-2.40
Pancreas/All 0 4.08 0.00 0.00-0.74 1 1.33 0.75 0.02-4.20
Colon/All 13 9.02 1.44 0.77-2.47 2 2.98 0.67 0.08-2.43
Stomach/Mothers 5 2.87 1.74 0.57-4.06 4 1.10 3.65 0.99-9.35
Thyroid/All 4 0.94 4.25 1.16-10.89 0 0.25 0.00 0.00-12.00
Thyroid/Mothers 3 0.67 4.49 0.93-13.12 0 0.18 0.00 0.00-16.67
0, observed; E, expected.
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All of the four observed cases of thyroid cancer occurred among
parents of probands with papillary carcinoma. In three of these
four parent-child couples, we have secure information on the
histotype of thyroid cancer for the parent, as both parent and child
were included as probands in our case series. In two instances, the
parent also had papillary carcinoma, while in the third couple the
parent had follicular carcinoma. The excess risk of stomach
cancer, on the other hand, was evidence only among mothers
whose children were diagnosed with a follicular carcinoma (SIR
3.65, 95% CI 0.99-9.35). In Table 5, some selected results are
presented separately by histopathological type of the proband.
DISCUSSION
An overall history ofcancer in the parents was not linked to the risk
ofdifferentiatednon-medullary carcinomaofthe thyroid in this large,
population-based case-control study. However, some associations
emerged,thoughofmarginal significance, between certain histotypes
of thyroid cancer and parental cancer at specific sites. The risk of
follicular carcinoma among women was associated with a history of
maternal cancer. Compared with the general population, mothers of
patients with follicular thyroid carcinoma had an increased risk of
stomach cancer, while the risk of having thyroid cancer was higher
among parents whose children had papillary carcinoma.
This last finding is in agreement with previous observations
(Ozaki etal, 1988; Fischer et al, 1989; Ron etal, 1991; Gorson et al,
1992; Kobahashi et al, 1995). As in some studies (Ron et al, 1991;
Kobayashi et al, 1995), we did not observe a complete concordance
between the tumour histotype of the child and that of the parent.
The role ofincreased medical surveillance in these families cannot
be ruled out; on the other hand, the association was quite strong,
and ourestimate ofafourfold increase in riskmighteven be conser-
vative if, in these families, differentiated non-medullary thyroid
carcinoma occurred at a younger age than in the general population,
but had the same overall good prognosis (Akslen et al, 1991; Levi
et al, 1992). The excess of parathyroid adenomas among mothers
of thyroid cancer cases deserves attention. Again, chance and
increased diagnostic intensity are plausible explanations, but a
multiple endocrine involvement in these families is also possible.
The increased risk ofstomach cancer among mothers is intriguing,
if real. An expression, at the maternal lineage, of familial polyposis
coli (FAP) syndromes (Plail et al, 1987) does not seem likely, as the
incidence ofcolorectal tumours was close to the expected, and FAP
was more often associated with papillary carcinoma. None of the
gastric tumours occurred in association with other tumours, and the
incidence of pancreatic cancer, which is increased in patients with
FAP (Giardiello et al, 1993), was even decreased in this cohort of
parents compared with the general population. Although not well
recognized, a linkage has been proposed between iodine deficiency
and carcinogenesis of the stomach (Venturi et al, 1993). Thyroid
cancer has been repeatedly associated with iodine deficiency disor-
ders, such as goitres and thyroid nodules (Ron et al, 1987; Preston-
Martin et al, 1987; D' Avanzoet al, 1995) and with residence in areas
of endemic goitre (Franceschi et al, 1989). Shared dietary habits
among members ofthese families could, at least in part, explain this
finding. A gene-environment interaction (Schatzkin et al, 1995) can
also be hypothesized, if a putative genetic defect might induce an
altered cell response to iodine deficiency or alter iodine metabolism
in several target organs (e.g. thyroid and stomach). The plausibility
of a link with iodine deficiency may be increased given that the
excess ofstomach cancer appeared among mothers ofprobands with
follicularcarcinoma. The incidence ofthis histological type seems to
be relatively high in areas of iodine deficiency (Belfiore et al, 1987;
Franssila et al, 1981),and women may be more sensitive to an insuf-
ficient iodine intake (Galanti etal, 1995).
The risk deficit of cancers at specific sites may be owing to
chance,given the high number oftested associations. Alternatively,
it may reflect the selection of 'healthy reproducers' and 'healthy
survivors', but one would then expect a deficit of incidence for all
cancers. The use ofnational data in the calculation ofthe expected
number of cancers might also explain to a very small extent the
deficits of lung and breast cancer, if the regional rates are lower
than the national ones. The deficit of lung cancer among fathers
may indicate that smoking is uncommon in these families. In
previous case-control studies, there was a lower proportion of
women smokers among thyroid cancer cases (Hallquist et al, 1993)
or among their mothers (Paoff et al, 1995) compared with their
corresponding controls. Familial environment may influence the
uptake of smoking habits (Evans et al, 1995). Tobacco smoking is
associated to pancreatic cancer (Silverman et al, 1994), another
cancer site ofwhich there was a decreased incidence.
A familial association ofbreast and thyroid cancer was detected
in a study of first-degree relatives (Goldgar et al, 1994), but not in
other epidemiological studies (Ron et al, 1987, McTiernan et al,
1987). Our cohort consisted, by definition, of parous women only,
and this may account for the decreased risk of breast cancer
(Lambe et al, 1996), paralleled by a concomitant deficit ofovarian
cancer (Adami et al, 1994). The possibility that an excess of inci-
dence of breast cancer occurred, in this cohort, at a younger age,
cannot be ruled out; however, if the protection conferred by parity
was counteracted by an increased familial risk, the net effect would
not have been the marked reduction in risk that we observed.
The decreased risk of differentiated thyroid carcinoma among
women with increasing parental age at their birth is not easily
explainable. If not an artifact or owing to chance, high parental age
may reflect socialclass orbirth orderofthe indexchild,withpossible
differences in nutritional factors or exposure to lowermaternal preg-
nancy hormones (Panagiotopoulou et al, 1990). Although this was
not the focus of our study, this finding deserves further attention, in
the light of the linkage between hormonal and metabolic factors and
thyroid cancer among women (Goodman etal, 1992).
This study has an inherent limitation in the information about the
diagnosis of cancer among the oldest parents, because death
records may lack both sensitivity and specificity. A more complete
family history of cancer including all first-degree relatives could
not be compiled at this stage. The strength ofthis study,on the other
hand, rests on several features: the thorough and uniform ascertain-
ment and histological verification ofa large series ofthyroid cancer
cases, the population-based design and the retrieval of information
on parental cancer free from selection and recall bias.
Ourfindings provide insights and indications for future research
in two directions. Firstly, they support the existing evidence that
some familial, possibly genetically inheritable, factors are associ-
ated with differentiated, non-medullary thyroid carcinoma.
Secondly, the role ofcommon environmental factors and lifestyles
is suggested in the occurrence of familial associations of thyroid
cancer with other malignant neoplasms.
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